![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
Tagged: immu, hgsi, rhhby pk, ep vantage
EP Vantage submits: Immunomedics (IMMU) has had an outstanding year. The small New-Jersey based company has produced some of the biggest growth in the microcap sector and has seen its shares more than double since January (Human Genome, OncoGenex Standout Smallcaps So Far in 2009, October 1,). What Immunomedics appears to have got right is the multiple targets it has for hard-to-treat disorders … Continue Reading »